Genomictree Inc. (228760.KQ)

KRW 23550.0

(3.06%)

Total Liabilities Summary of Genomictree Inc.

  • Genomictree Inc.'s latest annual total liabilities in 2023 was 7.81 Billion KRW , down -85.89% from previous year.
  • Genomictree Inc.'s latest quarterly total liabilities in 2024 Q2 was 7.89 Billion KRW , up 4.57% from previous quarter.
  • Genomictree Inc. reported annual total liabilities of 55.35 Billion KRW in 2022, down -10.79% from previous year.
  • Genomictree Inc. reported annual total liabilities of 62.05 Billion KRW in 2021, up 174.07% from previous year.
  • Genomictree Inc. reported quarterly total liabilities of 7.55 Billion KRW for 2024 Q1, down -3.32% from previous quarter.
  • Genomictree Inc. reported quarterly total liabilities of 7.81 Billion KRW for 2023 Q4, down -13.31% from previous quarter.

Annual Total Liabilities Chart of Genomictree Inc. (2023 - 2016)

Historical Annual Total Liabilities of Genomictree Inc. (2023 - 2016)

Year Total Liabilities Total Liabilities Growth
2023 7.81 Billion KRW -85.89%
2022 55.35 Billion KRW -10.79%
2021 62.05 Billion KRW 174.07%
2020 22.64 Billion KRW 361.64%
2019 4.9 Billion KRW 70.97%
2018 2.86 Billion KRW 42.44%
2017 2.01 Billion KRW 2.97%
2016 1.95 Billion KRW 0.0%

Peer Total Liabilities Comparison of Genomictree Inc.

Name Total Liabilities Total Liabilities Difference
HLB Co., Ltd. 169.47 Billion KRW 95.39%
iNtRON Biotechnology, Inc. 1.88 Billion KRW -315.466%
BINEX Co., Ltd. 75.68 Billion KRW 89.678%
Bioneer Corporation 80.61 Billion KRW 90.309%
Anterogen.Co.,Ltd. 19.98 Billion KRW 60.913%
MEDIPOST Co., Ltd. 135.73 Billion KRW 94.244%
CrystalGenomics, Inc. 97.82 Billion USD 92.014%
Helixmith Co., Ltd 73.55 Billion KRW 89.379%
Chabiotech Co.,Ltd. 1069.23 Billion KRW 99.269%
Medy-Tox Inc. 137.14 Billion KRW 94.303%
Peptron, Inc. 16.36 Billion KRW 52.274%
Amicogen, Inc. 248.12 Billion KRW 96.851%
Genexine, Inc. 79.68 Billion KRW 90.196%
HLB Therapeutics Co.,Ltd. 29.27 Billion KRW 73.315%
LegoChem Biosciences, Inc. 41.28 Billion KRW 81.075%
ALTEOGEN Inc. 108.25 Billion KRW 92.784%
PharmaResearch Co., Ltd. 73.08 Billion KRW 89.311%
SillaJen, Inc. 19.4 Billion KRW 59.733%
JETEMA, Co., Ltd. 179.09 Billion KRW 95.638%
OliX Pharmaceuticals,Inc 52.48 Billion KRW 85.116%
MedPacto, Inc. 9.56 Billion KRW 18.331%
D&D Pharmatech 23.98 Billion KRW 67.429%
EASY BIO,Inc. 105.86 Billion KRW 92.621%
GI Innovation, Inc. 9.63 Billion KRW 18.928%